Roche today announced findings from a global survey highlighting the logistical and emotional challenges faced by people with diabetes. The Basel, Switzerland-based company — one of the largest diabetes tech companies in the world — reported findings from 4,326 people. Its research, based on data from a GWI research commissioned in September 2025, explores diabetes perceptions, […]
Diabetes
Tandem Diabetes care launches Mobi pump on Android phones
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it made its Mobi automated insulin delivery system available with Android devices. San Diego-based Tandem said Mobi, the world’s smallest, durable automated insulin delivery system, can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. In November, Tandem announced that it received […]
Modular Medical prices $12M public offering to support insulin pump
Modular Medical (Nasdaq:MODD) announced the pricing of a public offering worth proceeds of approximately $12 million. San Diego-based Modular Medical’s offering includes nearly 68.1 million shares of the company’s common stock and warrants to purchase up to an aggregate of 68.1 million shares. The company priced the offering at $0.1762 per share and accompanying warrant. […]
Judge tosses class action suit accusing Abbott of sharing CGM data with Meta, Google
An Illinois judge sided with Abbott (NYSE:ABT) in a lawsuit related to alleged data sharing with its continuous glucose monitors (CGMs). In September 2024, a lawsuit filed in the Northern District of Illinois alleged that tracking tools on Abbott’s FreeStyle Libre website expose private consumer information without their knowledge or consent. The company’s FreeStyle.Abbott website […]
Kevin Sayer returns from leave of absence to chair Dexcom board
Dexcom (Nasdaq:DXCM) announced today in an SEC filing that former CEO Kevin Sayer has returned from his leave of absence. Sayer notified the San Diego-based continuous glucose monitor (CGM) maker of his plan to return on Feb. 27, 2026. His return went into effect today, March 2, 2026, according to the filing. Upon his return, […]
Senseonics earns FDA IDE for next-gen Gemini CGM, posts Q4 revenue beat
Senseonics (NYSE:SENS) posted fourth-quarter results that proved mixed compared to Wall Street forecasts alongside a major pipeline announcement. Along with its fourth-quarter results, the company shared that it secured FDA investigational device exemption (IDE) for its self-powered, battery-enabled Gemini sensor. It enrolled the first patients in the IDE trial and expects to complete that in […]
Dexcom adds Google exec to its board
Dexcom (Nasdaq:DXCM) announced that it appointed Rick Osterloh to its board of directors, effective Feb. 26, 2026. Osterloh currently serves as SVP, Platforms and Devices at Google. There, he leads a unified group spanning the tech giant’s portfolio of advanced consumer technologies. San Diego-based Dexcom said in a news release that Osterloh offers significant experience […]
Trinity Biotech raises $25M as it looks to advance CGM+ system
Trinity Biotech (Nasdaq:TRIB) announced today that it entered into a $25 million Standby Equity Purchase Agreement (SEPA). The agreement with an affiliate of financing partner Yorkville Advisors Global provides the Dublin, Ireland-based company with additional funding to augment its commercialization initiatives and support its R&D programs. Under the SEPA, Trinity has the right, but not […]
Ascensia Diabetes Care has a new CEO
Ascensia Diabetes Care, a PHC Holdings subsidiary, today announced the appointment of Peter Bodlund as president and CEO. Bodlund succeeds Koichiro Sato, effective April 1, 2026. Sato continues in his roles as COO of the PHC Group and head of PHC Group’s Diabetes Management business. An experienced leader across global healthcare and life sciences organizations, […]
Medtronic launches MiniMed Go smart MDI system with Simplera sensor in Europe
Medtronic (NYSE:MDT) announced today that it launched its MiniMed Go smart multiple daily injection (MDI) system with the Simplera sensor. The system represents the first and only solution that integrates data from the InPen smart insulin pen and the Simplera continuous glucose monitor (CGM) sensor into a single mobile app. Medtronic (soon to separate its Diabetes […]
